VEGFA and rheumatoid arthritis: The molecules ALN-VSP and bevasiranib, targeting VEGF gene expression, and molecule AGN211745, targeting VEGF receptor I (VEGFRI), may also be used in inflammatory arthritis, where synovial angiogenesis plays an essential role in the early stage of RA by promoting inflammatory processes and joint destruction.